share_log

Stephens & Co. Maintains Equal-Weight on Lifecore Biomedical, Raises Price Target to $9

Benzinga ·  Sep 1, 2023 10:51

Stephens & Co. analyst Jacob Johnson maintains Lifecore Biomedical (NASDAQ:LFCR) with a Equal-Weight and raises the price target from $8 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment